Related Experiment Video
Updated: Apr 19, 2026

High Speed Droplet-based Delivery System for Passive Pumping in Microfluidic Devices
Published on: September 2, 2009
Cell dispensing in low-volume range with the immediate drop-on-demand technology (I-DOT)
Lena Schober1, Evy Büttner2, Christopher Laske2
1Department Laboratory Automation and Biomanufacturing Engineering, Fraunhofer Institute for Manufacturing Engineering and Automation IPA, Stuttgart, Germany lena.schober@ipa.fraunhofer.de.
The immediate drop-on-demand (I-DOT) technology offers precise, noncontact cell dispensing for microfabrication. This method ensures high cell viability and function, crucial for advanced cell-based assays.
Area of Science:
- Biotechnology
- Cell Biology
- Microfluidics
Background:
- Accurate cell handling is vital for microfabrication in cell-based assays.
- Existing methods risk cross-contamination and cell damage.
- The immediate drop-on-demand (I-DOT) technology was developed to address these challenges.
Purpose of the Study:
- To evaluate the performance and biological impact of the I-DOT technology.
- To assess cell viability, proliferation, and differentiation after I-DOT dispensing.
- To determine the suitability of I-DOT for precise cell dosage.
Main Methods:
- Utilized the I-DOT system for noncontact dispensing of cell suspensions.
- Tested with MCF-7 cell line, human fibroblasts, and human mesenchymal stem cells (hMSCs).
- Assessed cell viability, proliferation rates, and hMSC differentiation potential post-dispensing.
Main Results:
- I-DOT dispensing maintained cell viability comparable to controls across all tested cell types.
- Proliferation rates were similar to controls, with no observed apoptotic cells.
- The differentiation potential of human mesenchymal stem cells remained unimpaired.
Conclusions:
- The I-DOT technology provides accurate and flexible noncontact liquid handling for cell dispensing.
- It ensures high cell viability and functional integrity, crucial for cell-based assays.
- I-DOT technology shows significant potential for applications requiring precise cell dosage, including single-cell applications.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed I
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Stimuli-Activated
Ophthalmic Drug Delivery Systems

